Skip to content

Phio Pharmaceuticals Corp.

PHIO· NasdaqCore metricsCIK 1533040

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -5.08%
Market cap
$9.56M
11.95M shares
Filings
899
$0.00
FY 2020−100.0% FY20 yoy
-$4.16M
Q3 2026N/M FY25 yoy
-$4.27M
Q3 2026N/M FY25 yoy
-$10.32M
Q3 2026derivedN/M FY25 yoy
-$0.45
Q2 2025N/M FY24 yoy
$10.61M
Q3 2026+290.8% FY25 yoy
$9.56M
—
—
1.1×
-83.57%
—

FY2025 figures · derived

Price

$0.800150.30%$0.8099past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2020
$399.00K0FY 2012FY 2013FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020
PeriodEndedValueKindSource trail
FY 20202020-12-31$0reported
FY 20192019-12-31$21,000reported
FY 20182018-12-31$138,000reported
FY 20172017-12-31$15,000reported
FY 20162016-12-31$19,000reported
FY 20152015-12-31$34,000reported
FY 20132013-12-31$399,000reported
FY 20122012-12-31$97,000reported

Pharmaceutical preparations

Phio Pharmaceuticals Corp. is the 419th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR